| abstract |
IT REFERS TO A PHARMACEUTICAL COMPOSITION INCLUDING (S) -N- [2- (1,6,7,8-TETRAHIDRO-2H-INDEN [5,4-b] FURAN-8-IL) ETHYL] PROPIONAMIDE, ALSO NAMED RAMELTEON, WHICH IS A MELATONIN AGONIST, AND TO A COMBINATION THAT INCLUDES RAMELTEON AND ONE OR MORE DRUGS SELECTED FROM ANTIDEPRESSANTS OR ANTI-ANTI-ANTI-ANTI-ADDICTION SUCH AS FLUOXETINE, SERTRALINE, PAROXETINE, MIANSVOAMERIN, MILTALOPRAN, ESTABLISHMENT, FLUOXETINE, MIANSERIN, MILTALOPRAN, ESTABLISHMENT, FLUOXETINE, DIMALOXAMINE, MILTALOPRE, OTHERS . THIS COMPOSITION IS USEFUL FOR THE PREVENTION OR TREATMENT OF DEPRESSION OR ANXIETY DISORDERS IN PATIENTS WHO HAVE A BACKGROUND OF DIABETES, HYPERLIPIDEMIA, HYPERTENSION OR METABOLIC SYNDROME |